Borderline gestational diabetes mellitus and pregnancy outcomes

被引：64

作者：

Ju H. ^{[1
]}

Rumbold A.R. ^{[2
]}

Willson K.J. ^{[3
]}

Crowther C.A. ^{[1
]}

机构：

[1] Discipline of Obstetrics and Gynaecology, The University of Adelaide, Women's and Children's Hospital, North Adelaide, SA 5006, King William Road

[2] Menzies School of Health Research, Institute of Advanced Studies, Charles Darwin University, Casuarina, NT 0811

[3] Discipline of Public Health, The University of Adelaide, Adelaide

来源：

BMC Pregnancy and Childbirth | / 8卷 / 1期

基金：

英国医学研究理事会;

关键词：

Gestational Diabetes Mellitus; Oral Glucose Tolerance Test; Neonatal Intensive Care Unit; Gestational Diabetes; Pregnancy Induce Hypertension;

D O I：

10.1186/1471-2393-8-31

中图分类号：

学科分类号：

摘要：

Background: The impact of borderline gestational diabetes mellitus (BGDM), defined as a positive oral glucose challenge test (OGCT) and normal oral glucose tolerance test (OGTT), on maternal and infant health is unclear. We assessed maternal and infant health outcomes in women with BGDM and compared these to women who had a normal OGCT screen for gestational diabetes. Methods: We compared demographic, obstetric and neonatal outcomes between women participating in the Australian Collaborative Trial of Supplements with antioxidants Vitamin C and Vitamin E to pregnant women for the prevention of pre-eclampsia (ACTS) who had BGDM and who screened negative on OGCT. Results: Women who had BGDM were older (mean difference 1.3 years, [95% confidence interval (CI) 0.3, 2.2], p = 0.01) and more likely to be obese (27.1% vs 14.1%, relative risk (RR) 1.92, [95% CI 1.41, 2.62], p < 0.0001) than women who screened negative on OGCT. The risk of adverse maternal outcome overall was higher (12.9% vs 8.1%, RR 1.59, [95% CI 1.00, 2.52], p = 0.05) in women with BGDM compared with women with a normal OGCT. Women with BGDM were more likely to develop pregnancy induced hypertension (17.9% vs 11.8%, RR 1.51, [95% CI 1.03, 2.20], p = 0.03), have a caesarean for fetal distress (17.1% vs 10.5%, RR 1.63, [95% CI 1.10, 2.41], p = 0.01), and require a longer postnatal hospital stay (mean difference 0.4 day, [95% CI 0.1, 0.7], p = 0.01) than those with a normal glucose tolerance. Infants born to BGDM mothers were more likely to be born preterm (10.7% vs 6.4%, RR 1.68, [95% CI 1.00, 2.80], p = 0.05), have macrosomia (birthweight ≥4.5 kg) (4.3% vs 1.7%, RR 2.53, [95% CI 1.06, 6.03], p = 0.04), be admitted to the neonatal intensive care unit (NICU) (6.5% vs 3.0%, RR 2.18, [95% CI 1.09, 4.36], p = 0.03) or the neonatal nursery (40.3% vs 28.4%, RR 1.42, [95% CI 1.14, 1.76], p = 0.002), and have a longer hospital stay (p = 0.001). More infants in the BGDM group had Sarnat stage 2 or 3 neonatal encephalopathy (12.9% vs 7.8%, RR 1.65, [95% CI 1.04, 2.63], p = 0.03). Conclusion: Women with BGDM and their infants had an increased risk of adverse health outcomes compared with women with a negative OGCT. Intervention strategies to reduce the risks for these women and their infants need evaluation. © 2008 Ju et al; licensee BioMed Central Ltd.

引用

共 21 条

[1] Dabelea D., Snell-Bergeon J.K., Hartsfield C.L., Bischoff K.J., Hamman R.F., McDuffie R.S., Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program, Diabetes Care, 28, 3, pp. 579-584, (2005)
[2] ACOG Practice Bulletin. Clinical management guidelines for obstetricians-gynecologists. Number 55, September 2004 (replaces practice pattern number 6, October 1997). Management of Postterm Pregnancy, Obstet Gynecol, 104, 3, pp. 639-646, (2004)
[3] Cheung N.W., Byth K., The population health significance of gestational diabetes, Diabetes Care, 26, pp. 2005-2009, (2003)
[4] Acker D.B., Sachs B.P., Friedman E.A., Risk factors for shoulder dystocia, Obstet Gynecol, 66, 6, pp. 762-768, (1985)
[5] Langer O., Yogev Y., Most O., Xenakis E.M., Gestational diabetes: The consequences of not treating, Am J Obstet Gynecol, 192, pp. 989-997, (2005)
[6] Langer O., Rodriguez D.A., Xenakis E.M., McFarland M.B., Berkus M.D., Arrendondo F., Intensified versus conventional management of gestational diabetes, Am J Obstet Gynecol, 170, pp. 1036-1047, (1994)
[7] Soler N., Soler S., Malins J., Neonatal morbidity among infants of diabetic mothers, Diabetes Care, 1, (1978)
[8] Kim C., Newton K.M., Knopp R.H., Gestational diabetes and the incidence of type 2 diabetes: A systematic review, Diabetes Care, 25, pp. 1862-1868, (2002)
[9] Dodd J.M., Crowther C.A., Antoniou G., Baghurst P., Robinson J.S., Screening for gestational diabetes: The effect of varying blood glucose definitions in the prediction of adverse maternal and infant health outcomes, Aust N Z J Obstet Gynaecol, 47, 4, pp. 307-312, (2007)
[10] Sermer M., Naylor C.D., Gare D.J., Kenshole A.B., Ritchie J.W., Farine D., Cohen H.R., McArthur K., Holzapfel S., Biringer A., Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project, Am J Obstet Gynecol, 173, 1, pp. 146-156, (1995)

← 1 2 3 →